Company Overview

C & O Pharmaceutical Technology (Holdings) Limited engages in the research and development, manufacture, marketing, and distribution of branded and third party pharmaceutical products primarily in China. The company offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. Its products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, otitis media, sinusitis, acute pharyngitis, UTI, hypertension, migraine, pancreatitis, upper gastrointestinal hemorrhage, pancreatic fistula, intestinal fistula, biliary fistula, breast cancer, ...

C & O Pharmaceutical Technology (Holdings) Limited engages in the research and development, manufacture, marketing, and distribution of branded and third party pharmaceutical products primarily in China. The company offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. Its products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, otitis media, sinusitis, acute pharyngitis, UTI, hypertension, migraine, pancreatitis, upper gastrointestinal hemorrhage, pancreatic fistula, intestinal fistula, biliary fistula, breast cancer, carnitine deficiency, allergies, hay fever, angioedema, urticaria, respiratory disorders, and cancer; hepatitis, tumor, rheumatoid arthritis, AIDS, and other primary immuno deficiencies; venous, diabetic retinopathy, microvascular, and gastrointestinal motility disorders; and respiratory tract, urinary tract, blood, abdomen, or bones infection, as well as common cold, influenza, throat and bronchial irritation, coughs, runny nose, nasal congestion, and sore throat in children. The company also offers products for treatment of infections caused by gram-positive, gram-negative, and anaerobic bacteria; and bacteria or micro-organisms sensitive to amoxicillin, clarithromycin, cefuroxime, clindamycin, azithromycin, cefuroxil, cefoperazone, cefuroxime, cefradine, and flucloxacillin. In addition, it is involved in the research, development, and sale of technical know-how relating to pharmaceutical products; and provision of contract research and manufacturing services, as well as offers product registration and distribution services. The company was incorporated in 2003 and is based in Tsim Sha Tsui, Hong Kong. As of October 12, 2011, C & O Pharmaceutical Technology Holdings Limited operates as a subsidiary of Shionogi & Co. Ltd.

Key Executives for C & O Pharmaceutical Technology Holdings Limited

Similar Private Companies By Industry

Recent Private Companies Transactions